Seven medical researchers have been awarded a CSL Research Acceleration Initiative (RAI) partnership.
Each researcher will receive up to $500,000 over two years to fast-track the discovery of innovative biotherapies to address unmet medical needs.
The seven Global RAI awardees, selected via the 2021 call for proposals, are from The University of Queensland, the University of Newcastle and ANZAC Research Institute in Australia, the University of Pennsylvania in the US, Justus Liebig University Giessen and University Hospital of Ludwig Maximilian University of Munich in Germany, and the University of Basel in Switzerland.
CSL’s Head of Global Research Innovation Dr Marthe D’Ombrain said, “Through our Global Research Acceleration Initiative, we are able to tap into and support research innovation happening in all corners of the world. We are looking forward to collaborating with our new partners to support the development of their exciting discoveries.”
The Global RAI awardees’ research targets unmet medical needs across CSL’s therapeutic areas, including immunology, transplant, respiratory, hematology, and cardiovascular and metabolic disease.
Dr D’Ombrain continued, “We want to look back in years to come and see projects accelerated via our Research Acceleration Initiative making a difference to the lives of patients across the globe.
“We look forward to helping transform these ideas into what we hope will ultimately be ground-breaking therapies to improve the lives of people living with these conditions.”